Icotinib (BPI-2009H), a novel EGFR tyrosine kinase...

Lung Cancer 2012 / 5 Vol. 76; Iss. 2

Icotinib (BPI-2009H), a novel EGFR tyrosine kinase inhibitor, displays potent efficacy in preclinical studies

Tan, Fenlai, Shen, Xiaoyan, Wang, Dechang, Xie, Guojian, Zhang, Xiaodong, Ding, Lieming, Hu, Yunyan, He, Wei, Wang, Yanping, Wang, Yinxiang
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
76
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2011.10.023
Date:
May, 2012
File:
PDF, 580 KB
english, 2012
Conversion to is in progress
Conversion to is failed